{"id":858,"date":"2020-04-14T18:46:26","date_gmt":"2020-04-14T16:46:26","guid":{"rendered":"https:\/\/www.irbm.com\/?p=8842"},"modified":"2020-08-21T15:17:40","modified_gmt":"2020-08-21T13:17:40","slug":"porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april","status":"publish","type":"post","link":"https:\/\/www.cnccs.it\/en\/2020\/04\/14\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\/","title":{"rendered":"Porta a Porta, interview with Piero Di Lorenzo &#x25aa; Rai 1 \u2013 14th April"},"content":{"rendered":"<iframe loading=\"lazy\" title=\"Porta a Porta, interview with Piero Di Lorenzo - Rai 1 - 14th April\" width=\"1220\" height=\"686\" src=\"https:\/\/www.youtube.com\/embed\/hACGP6xNvw0?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p style=\"text-align: justify;\">BRUNO VESPA<\/p>\n<p style=\"text-align: justify;\">We have with us the CEO of Advent IRBM. There has been a lot a noise about this company that is based near Rome, in Pomezia, because together with a prestigious institute in Oxford, it has developed a vaccine. It is a vaccine that will be tried out on humans in the UK from the end of April. Good evening Mr. Di Lorenzo. How did this idea come about? Was it first developed in Pomezia or in Oxford?<\/p>\n<p style=\"text-align: justify;\">DI LORENZO<\/p>\n<p style=\"text-align: justify;\">Good evening.<\/p>\n<p style=\"text-align: justify;\">BRUNO VESPA<\/p>\n<p style=\"text-align: justify;\">You have 200 researchers, how do they coordinate with their colleagues in England?<\/p>\n<p style=\"text-align: justify;\">DI LORENZO<\/p>\n<p style=\"text-align: justify;\">We\u2019ve been working with Oxford for 10 years: the collaboration between us is well-established and in this ground-breaking area they have synthesized the gene of the Spike protein. Once the Chinese had published the sequencing of the virus, on January 10<sup>th<\/sup>, within a few days Oxford sent us the synthesized gene of the Spike protein so that we could characterize the adenovirus, i.e. the vehicle within which the disabled gene of the protein has to be placed. It is this protein, the small red corona of the virus, that causes contagion, enabling it to enter the body and create the conditions for the body to react by creating antibodies. Obviously, the original idea for the study came from Oxford, then we were called on to collaborate on this project, as we have done with many other projects. Our contribution is, as I always put it, as if we had been called upon by Ferrari to supply tires for the Grand Prix: so we are grateful for this recognition from what, for us, is the biggest institute in the world for the study of vaccines.<\/p>\n<p style=\"text-align: justify;\">BRUNO VESPA<\/p>\n<p style=\"text-align: justify;\">So you are providing the tires, and you will be sending them to Ferrari within a couple of weeks. Will human trials begin right away?<\/p>\n<p style=\"text-align: justify;\">DI LORENZO<\/p>\n<p style=\"text-align: justify;\">Yes, by the end of April we\u2019ll be sending the first batch we\u2019ve produced in our laboratories in Pomezia. They, in the meantime, are selecting 550 healthy volunteers to take part in the tests \u2026 I think that by May they will have selected the 500 volunteers and will vaccinate them right away. We anticipate being able to understand the actual effectiveness of the vaccine by the autumn.<\/p>\n<p style=\"text-align: justify;\">BRUNO VESPA<\/p>\n<p style=\"text-align: justify;\">So will we also have some doses to start with, if all goes to plan, to vaccinate health care and law enforcement workers, basically those who are a bit more exposed?<\/p>\n<p style=\"text-align: justify;\">DI LORENZO<\/p>\n<p style=\"text-align: justify;\">So the vaccine is being tested in England because, as I was saying, it was there that Sarah Gilbert, the internationally-recognized, highly-esteemed giant in the world of vaccines, first set up this research. Those tests will be carried out in England, once the scientific tests have provided a response, according to the official standards of approval of the British regulatory authority. During this time the batches that have been produced by then will be made available to qualifying hospitals, in other words they will be freely distributed during that period as another test.<\/p>\n<p style=\"text-align: justify;\">BRUNO VESPA<\/p>\n<p style=\"text-align: justify;\">Sorry, but does that include Italy too?<\/p>\n<p style=\"text-align: justify;\">DI LORENZO<\/p>\n<p style=\"text-align: justify;\">This whole project was set up with financing from the CEPI, which is a supranational body financed by the British and Norwegian governments, so, as we know, the ones who pay are entitled to take precedence. But I haven\u2019t lost hope of Italy being involved. I have spoken about it to the relevant Ministers, with Minister Manfredi and Minister Speranza, they are also very committed to doing whatever it takes to involve Italy in this distribution.<\/p>\n<p style=\"text-align: justify;\">BRUNO VESPA<\/p>\n<p style=\"text-align: justify;\">Well thank you Mr. Di Lorenzo, well done and good luck. Let\u2019s hope we can get some too. In the meantime, let\u2019s hope it actually works and we can benefit from it.<\/p>\n[\/vc_column_text][\/vc_column][\/vc_row]","protected":false},"excerpt":{"rendered":"<p>BRUNO VESPA We have with us the CEO of Advent IRBM. There has been a lot a noise about this company that is based near Rome, in Pomezia, because together with a prestigious institute in Oxford, it has developed a vaccine. It is a vaccine that will be tried out on humans in the UK &hellip;<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-858","post","type-post","status-publish","format-video","hentry","category-galleria","post_format-post-format-video"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Porta a Porta, interview with Piero Di Lorenzo &#x25aa; Rai 1 \u2013 14th April - CNCCS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cnccs.it\/en\/2020\/04\/14\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Porta a Porta, interview with Piero Di Lorenzo &#x25aa; Rai 1 \u2013 14th April - CNCCS\" \/>\n<meta property=\"og:description\" content=\"BRUNO VESPA We have with us the CEO of Advent IRBM. There has been a lot a noise about this company that is based near Rome, in Pomezia, because together with a prestigious institute in Oxford, it has developed a vaccine. It is a vaccine that will be tried out on humans in the UK &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cnccs.it\/en\/2020\/04\/14\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\/\" \/>\n<meta property=\"og:site_name\" content=\"CNCCS\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-14T16:46:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-08-21T13:17:40+00:00\" \/>\n<meta name=\"author\" content=\"info@iwebyou.it\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"info@iwebyou.it\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/en\\\/2020\\\/04\\\/14\\\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/en\\\/2020\\\/04\\\/14\\\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\\\/\"},\"author\":{\"name\":\"info@iwebyou.it\",\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/#\\\/schema\\\/person\\\/056c35474ff146b46144a0d30e7d1fa9\"},\"headline\":\"Porta a Porta, interview with Piero Di Lorenzo &#x25aa; Rai 1 \u2013 14th April\",\"datePublished\":\"2020-04-14T16:46:26+00:00\",\"dateModified\":\"2020-08-21T13:17:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/en\\\/2020\\\/04\\\/14\\\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\\\/\"},\"wordCount\":670,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/#organization\"},\"articleSection\":[\"Photo and Video Gallery\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/en\\\/2020\\\/04\\\/14\\\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\\\/\",\"url\":\"https:\\\/\\\/www.cnccs.it\\\/en\\\/2020\\\/04\\\/14\\\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\\\/\",\"name\":\"Porta a Porta, interview with Piero Di Lorenzo &#x25aa; Rai 1 \u2013 14th April - CNCCS\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/#website\"},\"datePublished\":\"2020-04-14T16:46:26+00:00\",\"dateModified\":\"2020-08-21T13:17:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/en\\\/2020\\\/04\\\/14\\\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cnccs.it\\\/en\\\/2020\\\/04\\\/14\\\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/en\\\/2020\\\/04\\\/14\\\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cnccs.it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Porta a Porta, interview with Piero Di Lorenzo &#x25aa; Rai 1 \u2013 14th April\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/#website\",\"url\":\"https:\\\/\\\/www.cnccs.it\\\/\",\"name\":\"CNCCS\",\"description\":\"Collezione nazionale di composti chimici e centro screening\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cnccs.it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/#organization\",\"name\":\"CNCCS\",\"url\":\"https:\\\/\\\/www.cnccs.it\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cnccs.it\\\/wp-content\\\/uploads\\\/2016\\\/07\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.cnccs.it\\\/wp-content\\\/uploads\\\/2016\\\/07\\\/logo.png\",\"width\":856,\"height\":133,\"caption\":\"CNCCS\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cnccs.it\\\/#\\\/schema\\\/person\\\/056c35474ff146b46144a0d30e7d1fa9\",\"name\":\"info@iwebyou.it\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Porta a Porta, interview with Piero Di Lorenzo &#x25aa; Rai 1 \u2013 14th April - CNCCS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cnccs.it\/en\/2020\/04\/14\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\/","og_locale":"en_US","og_type":"article","og_title":"Porta a Porta, interview with Piero Di Lorenzo &#x25aa; Rai 1 \u2013 14th April - CNCCS","og_description":"BRUNO VESPA We have with us the CEO of Advent IRBM. There has been a lot a noise about this company that is based near Rome, in Pomezia, because together with a prestigious institute in Oxford, it has developed a vaccine. It is a vaccine that will be tried out on humans in the UK &hellip;","og_url":"https:\/\/www.cnccs.it\/en\/2020\/04\/14\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\/","og_site_name":"CNCCS","article_published_time":"2020-04-14T16:46:26+00:00","article_modified_time":"2020-08-21T13:17:40+00:00","author":"info@iwebyou.it","twitter_card":"summary_large_image","twitter_misc":{"Written by":"info@iwebyou.it","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cnccs.it\/en\/2020\/04\/14\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\/#article","isPartOf":{"@id":"https:\/\/www.cnccs.it\/en\/2020\/04\/14\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\/"},"author":{"name":"info@iwebyou.it","@id":"https:\/\/www.cnccs.it\/#\/schema\/person\/056c35474ff146b46144a0d30e7d1fa9"},"headline":"Porta a Porta, interview with Piero Di Lorenzo &#x25aa; Rai 1 \u2013 14th April","datePublished":"2020-04-14T16:46:26+00:00","dateModified":"2020-08-21T13:17:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cnccs.it\/en\/2020\/04\/14\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\/"},"wordCount":670,"publisher":{"@id":"https:\/\/www.cnccs.it\/#organization"},"articleSection":["Photo and Video Gallery"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.cnccs.it\/en\/2020\/04\/14\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\/","url":"https:\/\/www.cnccs.it\/en\/2020\/04\/14\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\/","name":"Porta a Porta, interview with Piero Di Lorenzo &#x25aa; Rai 1 \u2013 14th April - CNCCS","isPartOf":{"@id":"https:\/\/www.cnccs.it\/#website"},"datePublished":"2020-04-14T16:46:26+00:00","dateModified":"2020-08-21T13:17:40+00:00","breadcrumb":{"@id":"https:\/\/www.cnccs.it\/en\/2020\/04\/14\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cnccs.it\/en\/2020\/04\/14\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.cnccs.it\/en\/2020\/04\/14\/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cnccs.it\/"},{"@type":"ListItem","position":2,"name":"Porta a Porta, interview with Piero Di Lorenzo &#x25aa; Rai 1 \u2013 14th April"}]},{"@type":"WebSite","@id":"https:\/\/www.cnccs.it\/#website","url":"https:\/\/www.cnccs.it\/","name":"CNCCS","description":"Collezione nazionale di composti chimici e centro screening","publisher":{"@id":"https:\/\/www.cnccs.it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cnccs.it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.cnccs.it\/#organization","name":"CNCCS","url":"https:\/\/www.cnccs.it\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cnccs.it\/#\/schema\/logo\/image\/","url":"https:\/\/www.cnccs.it\/wp-content\/uploads\/2016\/07\/logo.png","contentUrl":"https:\/\/www.cnccs.it\/wp-content\/uploads\/2016\/07\/logo.png","width":856,"height":133,"caption":"CNCCS"},"image":{"@id":"https:\/\/www.cnccs.it\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.cnccs.it\/#\/schema\/person\/056c35474ff146b46144a0d30e7d1fa9","name":"info@iwebyou.it"}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"CNCCS","distributor_original_site_url":"https:\/\/www.cnccs.it\/en","push-errors":false,"_links":{"self":[{"href":"https:\/\/www.cnccs.it\/en\/wp-json\/wp\/v2\/posts\/858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cnccs.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cnccs.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cnccs.it\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cnccs.it\/en\/wp-json\/wp\/v2\/comments?post=858"}],"version-history":[{"count":3,"href":"https:\/\/www.cnccs.it\/en\/wp-json\/wp\/v2\/posts\/858\/revisions"}],"predecessor-version":[{"id":952,"href":"https:\/\/www.cnccs.it\/en\/wp-json\/wp\/v2\/posts\/858\/revisions\/952"}],"wp:attachment":[{"href":"https:\/\/www.cnccs.it\/en\/wp-json\/wp\/v2\/media?parent=858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cnccs.it\/en\/wp-json\/wp\/v2\/categories?post=858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cnccs.it\/en\/wp-json\/wp\/v2\/tags?post=858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}